Skip to content

Effect of different volumes of spinal anesthesia injection on the demand of ropivacaine for spinal anesthesia in cesarean section

Effect of different volumes of spinal anesthesia injection on the demand of ropivacaine for spinal anesthesia in cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115756
Enrollment
Unknown
Registered
2025-12-30
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia for cesarean section

Interventions

6ml group:Isobaric ropivacaine spinal anesthesia injection 6ml
3ml group:Isobaric ropivacaine spinal anesthesia injection 3ml

Sponsors

Zhejiang Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. ASA 2 grade; 2.(2) Women aged 18 to 40 years old; 3.(3) Weight = 150cm; 4.(4) gestational age >= 37 weeks. 5.(5) Elective singleton cesarean section;

Exclusion criteria

Exclusion criteria: 1. Intraspinal anesthesia is contraindicated; 2. Those who are allergic to amide local anesthetics; 3. Gestational hypertension or preeclampsia; 4. Gestational diabetes mellitus; 5. Asthma and heart disease requiring treatment; 6. Those who refuse to sign the informed consent; 7. Other conditions: such as rupture of membranes, active labor, cesarean section of twin and multiple pregnancies, intrauterine growth restriction, placenta previa, fetal congenital anomalies, etc.

Design outcomes

Primary

MeasureTime frame
Success or failure of spinal anesthesia in cesarean section;

Secondary

MeasureTime frame
Adverse effects;

Countries

China

Contacts

Public ContactXiaowen Guo

Zhejiang Provincial Hospital of TCM

guoxiaowen1315@hotmail.com+86 571 8706 8001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026